Stirling Products Limited (a public Australia company) is an animal healthcare company focussed on the development and commercialisation of metabolic modifiers for a range of applications in international animal healthcare markets).
Stirling is developing and commercialising technologies associated with its lead pharmaceutical compounds - R-salbutamol - a highly purified version of Salbutamol (also known as Albuterol) and ProVale™ a highly purified beta glucan. Both products have potential application as growth agents in livestock and for companion animals (eg cats and dogs). R-salbutamol is also being developed as a product for the treatment of respiratory disorders in horses and for obesity in dogs and cats.
Send to a friend
Copyright © 1999-2008 Engormix.com - All Rights Reserved
|
|
|
This company has no videos published. |
|
This company has no articles published. |
|
This company has no professionals registered. |
|
This company has no participation in forums. |
|
This company has no news published. |
|
This company has no participation at events. |
|